Leptomeningeal metastases in non-small-cell lung cancer

This publication has 80 references indexed in Scilit:

• ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis
  Lung Cancer, 2012
• Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy
  Journal of Thoracic Oncology, 2012
• "Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer
  Neuro-Oncology, 2011
• CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant
  Cancer Cell, 2011
• Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation
  Clinical Cancer Research, 2011
• Leptomeningeal metastasis
  Current Opinion in Oncology, 2010
• Regulation of P-glycoprotein and other ABC drug transporters at the blood–brain barrier
  Trends in Pharmacological Sciences, 2010
• Comparison of metastatic brain tumour models using three different methods: the morphological role of the pia mater
  International Journal of Experimental Pathology, 2007
• Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor–Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors
  Clinical Cancer Research, 2006
• Leptomeningeal carcinomatosis
  Cancer Treatment Reviews, 1999